HUMA

2.67

2.20% -0.06

Dopo l'orario di chiusura: 2.70 0.03 +1.12%

Humacyte Inc (HUMA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché HUMA Giù? Forum Previsione

Precedente Chiudi:

$2.73

Aprire:

$2.695

Volume 24 ore:

4.05M

Relative Volume:

1.04

Capitalizzazione di mercato:

$414.17M

Reddito:

Utile/perdita netta:

$-110.78M

Rapporto P/E:

-2.4953

EPS:

-1.07

Flusso di cassa netto:

$-75.59M

1 W Prestazione:

+10.33%

1M Prestazione:

+19.73%

6M Prestazione:

-42.08%

1 anno Prestazione:

-66.87%

Intervallo 1D:

$2.52

$2.72

Intervallo di 1 settimana:

$2.28

$2.82

Portata 52W:

$1.15

$9.79

Humacyte Inc Stock (HUMA) Company Profile

Nome

Humacyte Inc

Settore

Healthcare (1161)

Industria

Biotechnology (651)

Telefono

919-313-9633

Indirizzo

2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM

Dipendente

220

Cinguettio

Prossima data di guadagno

2025-03-28

Ultimi documenti SEC

HUMA's Discussions on Twitter

Confronta HUMA con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HUMA Humacyte Inc	2.67	356.77M	0	-110.78M	-75.59M	-1.07
VRTX Vertex Pharmaceuticals Inc	472.27	120.73B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	564.64	61.80B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	328.00	42.46B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	591.74	35.22B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	296.46	31.99B	3.81B	-644.79M	-669.77M	-6.24

Humacyte Inc Stock (HUMA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-05-14	Ripresa	H.C. Wainwright	Buy
2024-12-20	Reiterato	H.C. Wainwright	Buy
2023-12-11	Iniziato	H.C. Wainwright	Buy
2023-08-14	Aggiornamento	Piper Sandler	Underweight → Neutral
2023-06-22	Iniziato	Cantor Fitzgerald	Overweight
2022-05-16	Downgrade	Piper Sandler	Overweight → Underweight
2021-10-29	Iniziato	Cowen	Outperform
2021-09-24	Iniziato	Oppenheimer	Outperform
2021-09-22	Iniziato	BTIG Research	Buy
2021-09-16	Iniziato	Piper Sandler	Overweight

Mostra tutto

Humacyte Inc Borsa (HUMA) Ultime notizie

Jul 24, 2025

Will Humacyte Inc. Equity Warrant stock benefit from AI tech trendsBreakout stock performance - jammulinksnews.com

Jul 24, 2025

Humacyte rises on Symvess sale to military treatment facility - MSN

Jul 24, 2025

Jul 23, 2025

What drives Humacyte Inc. Equity Warrant stock priceExplosive trading opportunities - Autocar Professional

Jul 23, 2025

Humacyte, Inc. shares rise 1.47% after-hours after announcing first Symvess sale to U.S. Military Treatment Facility. - AInvest

Jul 23, 2025

Humacyte Inc. Equity Warrant Stock Analysis and ForecastRapid wealth multiplication - jammulinksnews.com

Jul 23, 2025

Humacyte shares climb 6% after first Symvess sale to U.S. military hospital - MSN

Jul 23, 2025

Is Humacyte Inc. Equity Warrant a good long term investmentUnprecedented profit potential - Autocar Professional

Jul 23, 2025

Humacyte stock rises after first Symvess sale to US Military facility - Investing.com India

Jul 23, 2025

Humacyte Announces First Symvess™ Sale to Military Treatment Facility - The Manila Times

Jul 23, 2025

Humacyte Breaks Into Military Healthcare: FDA-Approved Symvess Now Serving 200,000 Military Personnel - Stock Titan

Jul 23, 2025

What drives Humacyte Inc. stock priceFree Consultation - Autocar Professional

Jul 23, 2025

What analysts say about Humacyte Inc. stockMassive profits - jammulinksnews.com

Jul 23, 2025

Jul 22, 2025

Is Humacyte Inc. a good long term investmentOutstanding risk-reward balance - jammulinksnews.com

Jul 22, 2025

Humacyte Inc. Stock Analysis and ForecastFree Advanced Stock Screener Access - jammulinksnews.com

Jul 22, 2025

What analysts say about Humacyte Inc. Equity Warrant stockConsistently profitable trades - jammulinksnews.com

Jul 22, 2025

Jul 19, 2025